OU researchers help new medicine's approval | Health
Researchers at the University of Oklahoma Health Sciences Center are being recognized for their role in research that led to the approval of an anti-clotting drug.
The U.S. Food and Drug Administration just expanded the approved use of Xarelto to include treating and preventing deep vein thrombosis or pulmonary embolism in patients.
“This will improve the care of an estimated 600,000 patients each year in the United States who require treatment for DVT or PE,” said Gary Raskob, Ph.D., dean of the OU College of Public Health.
Raskob and the OU Health Sciences Center oversaw clinical studies that evaluated the safety and effectiveness of the drug when treating those problems.
Researchers say Xarelto was as effective as standard treatments and reduced serious bleeding side effects.
Upcoming Events near Norman
Most popular stories from nearby communities
- UPDATE: Police arrest man who turned himself in after killing his wife
- Driver escapes without a scratch after truck vs. train collision in Norman
- Disabled athletes take to the court to raise funds for a local organization
- Major Norman roadways to open soon
- UPDATE: Popular exit back open for commute in Norman